News
The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...
20h
MedPage Today on MSNPfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainAfter 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...
European Court of Justice found that the Commission failed to explain why text messages with Pfizer should be kept from the ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
45m
Dagens.com on MSNEU Court Rules Against Von der Leyen Over Pfizer Text MessagesThe European General Court says the Commission must disclose communications related to COVID-19 vaccine contracts.
Explore more
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
57m
Irish Mirror on MSNEU Commission wrong to refuse newspaper access to EU Chief's secret texts with Pfizer boss during pandemicA top European court has ruled that the European Commission was wrong to refuse The New York Times access to text messages ...
Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...
The European Commission did not provide credible reasons for rejecting a New York Times request to hand over text messages ...
For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...
A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results